Genzyme Reminds Sanofi Offer Is Too Low

Late yesterday, Sanofi-Aventis (SNY) requested that Genzyme (GENZ) allow its shareholders to decide for

BING NEWS:
  • MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis
    Yuichi Iwaki, M.D., Ph.D., MediciNova CEO commented, “The successful resolution of the Sanofi-Novartis litigation and the resulting monetary damages due to MediciNova both validates the value of our ...
    11/11/2024 - 10:17 am | View Link
  • Sanofi Q1 growth driven by Genzyme
    Genzyme continued to drive growth for Sanofi in the first quarter, helped along by the company’s vaccines unit, but diabetes drugs are still struggling. Net sales were €8,391 million ...
    04/25/2019 - 11:22 pm | View Link
  • Sanofi’s Genzyme presents positive phase 3 data for MS drug
    Genzyme, a subsidiary of Sanofi, has announced key data from its phase 3 clinical trials of its multiple sclerosis drug, Aubagio. The trials, called TOWER (Teriflunomide Oral in people With ...
    10/16/2012 - 1:00 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News